nexviadyme
sanofi b.v. - avalglucosidase alfa - glykogénová choroba typu ii - iné alimentárny trakt a metabolizmus výrobky, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glykogénová choroba typu ii - iné alimentárny trakt a metabolizmus výrobky, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
calcium gluconicum 10 % b. braun
b.braun melsungen ag, nemecko - elektrolyty - 39 - soli a ionty pro p.o. a parent. aplikÁciu
infusio glucosi 5 imuna
imuna pharm, a.s., slovensko - sacharidy - 76 - infundibilia
infusio glucosi 10 imuna
imuna pharm, a.s., slovensko - sacharidy - 76 - infundibilia
infusio glucosi 20 imuna
imuna pharm, a.s., slovensko - sacharidy - 76 - infundibilia
infusio glucosi 40 imuna
imuna pharm, a.s., slovensko - sacharidy - 76 - infundibilia
glukomer set glucotel
bodytel europe gmbh. schlachthofstrasse 1, bad wildungen 34537 hessen nemecko -
prúžky testovacie ku glukomeru glucotel
bodytel europe gmbh. schlachthofstrasse 1, bad wildungen 34537 hessen nemecko -
glukomer glucomen day
i-sens, inc. 43, banpo-daero 28-gil, seocho-gu 066 46 seoul kórea -